NasdaqCM - Nasdaq Real Time Price
USD
RedHill Biopharma Ltd. (RDHL)
0.4801
-0.0190
(-3.81%)
At close: October 16 at 4:00:00 PM EDT
0.4691
-0.0139
(-2.88%)
Pre-Market: 8:33:08 AM EDT
Loading chart for RDHL
- Previous Close
0.4991 - Open
0.5000 - Bid 0.3629 x 3000
- Ask 0.5200 x 100
- Day's Range
0.4800 - 0.5100 - 52 Week Range
0.4350 - 2.1400 - Volume
84,715 - Avg. Volume
2,057,540 - Market Cap (intraday)
4.267M - Beta (5Y Monthly) 4.90
- PE Ratio (TTM)
-- - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 10/19/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
RDHL
53.39%
MSCI WORLD (^990100-USD-STRD)
10.56%
1-Year Return
RDHL
67.99%
MSCI WORLD (^990100-USD-STRD)
0.00%
3-Year Return
RDHL
96.51%
MSCI WORLD (^990100-USD-STRD)
73.43%
5-Year Return
RDHL
99.99%
MSCI WORLD (^990100-USD-STRD)
56.19%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
As of 9/23/2026
-
Market Cap
3.31M
-
Enterprise Value
413.10k
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
6.02
-
Price/Book (mrq)
0.78
-
Enterprise Value/Revenue
1.44
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-22.37%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-10.87M
-
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
5.16M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
5.19M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.4801
-3.81%
Mkt Cap
4.267M
Industry
Drug Manufacturers—Specialty & Generic
0.7814
-7.64%
Mkt Cap
2.734M
Industry
Drug Manufacturers—Specialty & Generic
7.18
-4.77%
Mkt Cap
107.579M
Industry
Drug Manufacturers—Specialty & Generic
2.0400
+1.49%
Mkt Cap
22.168M
Industry
Drug Manufacturers—Specialty & Generic
26.34
-4.74%
Mkt Cap
3.306B
Industry
Drug Manufacturers—Specialty & Generic
0.7222
-1.01%
Mkt Cap
706.133M
Industry
Drug Manufacturers—Specialty & Generic
276.00
+2.60%
Mkt Cap
ILA
91.362M
Industry
Drug Manufacturers—Specialty & Generic
16.15
+12.15%
Mkt Cap
8.456B
Industry
Drug Manufacturers—Specialty & Generic
2,355.00
-3.60%
Mkt Cap
ILA
1.359B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
